MUC16 and neoplasm: Indeed, overexpressed broad spectrum (24) or specific sialic acid-containing ligands (e.g., MUC16, GD3, GD2, GT1b, etc.)are reported to be responsible for the impaired immune status in tumor microenvironment and serves as prognostic markers and therapy targets (23, 30, 31).